01.002 RWE TNT JULY 2022 D 18-07-2022

Introduction of e-prescribing in cancer improved safety 10-fold

  • Electronic prescribing records were introduced as they offer vastly improved communication between different healthcare professionals and patients, which was found to be the source of a high proportion of prescribing errors
  • A study was carried out at St Bartholomew’s Hospital, London to assess whether or not the introduction of electronic prescribing led to improved patient safety
  • A 10-fold reduction in errors was observed when comparing the results of this study to a previous audit of paper-based prescribing
  • Not only do cancer electronic prescribing records reduce errors, but they also provide a rich source of data that can be used to develop personalised treatment pathways
  • SVMPharma utilise electronic prescribing records in their unique methodologies for collecting and analysing data. Follow this link to learn more about our studies in NSCLC and Ovarian cancer.
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at